The germinal center reaction is essential for efficient humoral immunity, but it can also give rise to B cell lymphomas. Cre/loxP‐mediated conditional gene knock‐out or knock‐in can be used for the genetic manipulation of germinal center B cells in vivo. Here we present a novel allele, Cγ1‐CreERT2, that allows for timed activation of Cre recombinase in a small fraction of germinal center B cells. This allele will be useful to study normal and malignant germinal center B cell development in vivo.